Amber Shook
Private Equity Investor chez SK Capital Partners
Profil
Amber Shook is a professional who currently works as a Director at SK Capital Partners since 2019.
Prior to this, she worked as a Director at Catalent Pharma Solutions, Inc. from 2016 to 2019.
She completed her undergraduate degree from Drexel University in 1998 and earned an MBA from Kenan-Flagler Business School in 2017.
Postes actifs de Amber Shook
Sociétés | Poste | Début |
---|---|---|
SK Capital Partners
SK Capital Partners Investment ManagersFinance SK Capital Partners (SK Capital Partners) is a private equity firm founded in 2007 by Jamshid Keynejad and Barry B Siadat. The firm is headquartered in New York. | Private Equity Investor | 01/01/2019 |
Anciens postes connus de Amber Shook
Sociétés | Poste | Fin |
---|---|---|
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Directeur/Membre du Conseil | 30/04/2019 |
Formation de Amber Shook
Kenan-Flagler Business School | Masters Business Admin |
Drexel University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
SK Capital Partners
SK Capital Partners Investment ManagersFinance SK Capital Partners (SK Capital Partners) is a private equity firm founded in 2007 by Jamshid Keynejad and Barry B Siadat. The firm is headquartered in New York. | Finance |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Health Technology |